Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults
Clinical trial NCT01626820 · COMPLETED
Trial details
- NCT number
- NCT01626820
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-19
- Primary completion
- 2012-08-10
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.